Search research articles
Contact Us
Filters
Showing results (1-10 of 250) with videos related to
Page
of 25
Sort By:
Medical Hypotheses
|
August 30, 2005
Neuro-modulation, aminergic neuro-disinhibition and neuro-degeneration. Draft of a comprehensive theory for Alzheimer disease
H Peter Schmitt
Psychopharmacology
|
December 25, 2004
Pouring oil into the fire? On the conundrum of the beneficial effects of NMDA receptor antagonists in Alzheimer disease
H Peter Schmitt
Medical Hypotheses
|
April 4, 2006
Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders
H Peter Schmitt
Medical Hypotheses
|
March 6, 2007
Profiling the culprit in Alzheimer's disease (AD): bacterial toxic proteins - Will they be significant for the aetio-pathogenesis of AD and the transmissible spongiform encephalopathies?
H Peter Schmitt
Medical Hypotheses
|
January 31, 2006
epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis
H Peter Schmitt
Medical Hypotheses
|
June 1, 2005
On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease
H Peter Schmitt
Pediatric Nephrology (Berlin, Germany)
|
May 6, 2023
Sodium handling in pediatric patients on maintenance dialysis
Fabio Paglialonga, Claus Peter Schmitt
Pediatric Nephrology (Berlin, Germany)
|
November 27, 2012
The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children
Betti Schaefer, Claus Peter Schmitt
Frontiers in Physiology
|
February 1, 2019
Biocompatible Peritoneal Dialysis: The Target Is Still Way Off
Maria Bartosova, Claus Peter Schmitt
Pediatric Nephrology (Berlin, Germany)
|
March 12, 2004
The enigma of hyperparathyroidism in hypophosphatemic rickets
Claus Peter Schmitt, Otto Mehls
Page
of 25
Search research articles
Search
Showing results (1-10 of 250) with videos related to
Sort By:
Page
of 25
Medical Hypotheses
|
August 30, 2005
Neuro-modulation, aminergic neuro-disinhibition and neuro-degeneration. Draft of a comprehensive theory for Alzheimer disease
H Peter Schmitt
Psychopharmacology
|
December 25, 2004
Pouring oil into the fire? On the conundrum of the beneficial effects of NMDA receptor antagonists in Alzheimer disease
H Peter Schmitt
Medical Hypotheses
|
April 4, 2006
Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders
H Peter Schmitt
Medical Hypotheses
|
March 6, 2007
Profiling the culprit in Alzheimer's disease (AD): bacterial toxic proteins - Will they be significant for the aetio-pathogenesis of AD and the transmissible spongiform encephalopathies?
H Peter Schmitt
Medical Hypotheses
|
January 31, 2006
epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis
H Peter Schmitt
Medical Hypotheses
|
June 1, 2005
On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease
H Peter Schmitt
Pediatric Nephrology (Berlin, Germany)
|
May 6, 2023
Sodium handling in pediatric patients on maintenance dialysis
Fabio Paglialonga, Claus Peter Schmitt
Pediatric Nephrology (Berlin, Germany)
|
November 27, 2012
The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children
Betti Schaefer, Claus Peter Schmitt
Frontiers in Physiology
|
February 1, 2019
Biocompatible Peritoneal Dialysis: The Target Is Still Way Off
Maria Bartosova, Claus Peter Schmitt
Pediatric Nephrology (Berlin, Germany)
|
March 12, 2004
The enigma of hyperparathyroidism in hypophosphatemic rickets
Claus Peter Schmitt, Otto Mehls
Page
of 25